Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pantoprazole Sodium Hydrate (BY1023 (sodium hydrate)) is a proton pump inhibitor drug, used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
50 mg | 在庫あり | ¥ 7,000 | |||
100 mg | 在庫あり | ¥ 11,000 | |||
200 mg | 在庫あり | ¥ 16,500 | |||
500 mg | 在庫あり | ¥ 34,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 7,500 |
説明 | Pantoprazole Sodium Hydrate (BY1023 (sodium hydrate)) is a proton pump inhibitor drug, used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. |
別名 | SKF96022 sodium hydrate, BY1023 (sodium hydrate), SKF96022 (sodium hydrate) |
分子量 | 432.37 |
分子式 | C16H14F2N3NaO4S·3/2H2O |
CAS No. | 164579-32-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.23 mg/mL (10 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pantoprazole Sodium Hydrate 164579-32-2 Apoptosis Autophagy Membrane transporter/Ion channel Proton pump Potassium Channel SKF96022 sodium Inhibitor stability orally A431 Doxorubicin BY1023 anti-secretory Pantoprazole sodium sodium Hydrate release Proton Pump SKF96022 sodium hydrate H+/K+-ATPase BY1023 sodium BY1023 (sodium hydrate) BY 1023 SKF96022 exosome MCF-7 SKF-96022 anti-ulcer SKF96022 (sodium hydrate) inhibit BY-1023 PPI SKF 96022 SKF96022 sodium Hydrate inhibitor